Molecular exploration of the r91W (rPe65 gene) in tunisian patients with early onset retinal Dystrophy and early onset retinis pigmentosa

##plugins.themes.academic_pro.article.sidebar##

Published Nov 30, 2015
Download
pdf
Vol. 93 No. 7 (2015): Issue Jul 2015

##plugins.themes.academic_pro.article.main##

Ibtissem Chouchene
Leila Largueche
Kaouther Derouiche
Souad Mabrouk
Sonia Abdelhak
Leila El Matri

Abstract

SUMMARY
Background: Inherited retinal dystrophies are the major causes of blindness and visual impairment. Visual loss is due to neurosensory retinal and pigment epithelium cells degeneration. The most severe were Leber Congenital amaurosis (LCA), juvenile retinitis pigmentosa (RP) and early onset RP. The LCA and juvenile RP are called «Early Onset Retinal Dystrophy» (EORD).
Objective: Molecular exploration of the R91W (RPE65 gene) in Tunisian patients with Early Onset Retinal Dystrophy and early onset RP.
Methods: All patients underwent a complete ophthalmological and a general examinations. The R91W exploration was performed by direct sequencing of exon 4 of the RPE65 gene and enzyme digestion.
Results: Among 47 patients, 13 were from Nabeul. Twenty three had an EROD with a visual loss under the age of 2 years. Twenty four were with early onset RP and had these symptoms between the ages of 4 and 10 years. The best corrected visual acuity ranged from 2/10 to 1/60. Among the explored 94 chromosomes, the R91W (325C>T) allele was identified in heterozygous state in a sibling from Nabeul. The allele frequency was 2.12% (2/94).
Conclusion: All our patients had severe forms of RP with a decrease in visual acuity and a wide advanced retinal degeneration. The R91W mutation (325C>T) was not the major cause of EORD and early onset RP among Tunisian patients.

Keywords:

Early ouset retinis pigmentosa, RPE65 gene, R91W mutation

##plugins.themes.academic_pro.article.details##

References

  1. Hamel C. Retinitis pigmentosa. Orphanet. J. Rare Dis. 2006;11:40.
  2. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet 2006;368: 1795-1809.
  3. Dollfus H, Duffier JL. Rétinopathies pigmentaires et principaux syndromes associés. OEil et génétique: Rapport de la société française d'ophtalmologie. Masson 2005;243-260
  4. Foxman SG, Heckenlively JR, Bateman JB, Wirtschafter JD. Retinitis Pigmentosa Classification of Congenital and Early Onset. Arch Ophthalmol 1985; 103:1502-6.
  5. Bonneau D, Kaplan J, Girard G, Dufier JL. Autosomal inheritance of "senile" retinitis pigmentosa. A report of a family with consanguinity. Clin Genet 1992;42:199-200.
  6. Daiger SP, Bowne SJ, Sullivan LS. Perspective on genes and mutations causing retinitis pigmentosa. Arch Ophthalmol 2007;125 :151-58.
  7. RetNet «Retinal Information Network» https://sph.uth.edu/Retnet/sumdis. htm#B-diseases, Accès le 06 Octobre 2013, dernière mise à jour le 27 September 2013
  8. Thompson Da, Gyürüs P, Fleischer LL et al. Genetics and Phenotypes of RPE65 Mutations in inherited retinal degeneration. Invest Ophthalmol Vis Sci 2000;41:4293-9.
  9. Hanein S, Perrault I, Gerber S et al. Leber congenital amaurosis: comprehensive survey of the genetic heterogeneity, refinement of the clinical definition, and genotype-phenotype correlations as a strategy for molecular diagnosis. Hum Mutat 2004;23:306-17.
  10. Nicoletti A, Wong DJ, Kawase K et al. Molecular characterization of the human gene encoding an abundant 61 kDa protein specific to the retinal pigment epithelium. Hum Mol Genet 1995;4:641-9.
  11. Acland GM, Aguirre GD, Bennett J et al. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther 2005;12:1072-82.
  12. Bemelmans AP, Kostic C, Crippa SV et al. Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis. PLoS Med 2006;3:e347.
  13. Stein L, Roy K, Lei L, Kaushal S. Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis. Expert Opin Biol Ther 2011;11:429-39.
  14. Bennett J, Ashtari M, Wellman J et al. AAV2 gene therapy readministration in three adults with congenital blindness. Sci Transl Med 2012;4:1-10.
  15. Jacobson SG, Cideciyan AV, Ratnakaram R et al. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol 2012;130:9-24.
  16. Mowat FM, Breuwer AR, Bartoe JT et al. RPE65 gene therapy slows cone loss in Rpe65-deficient dogs. Gene Ther 2013;20:545-55.
  17. El Matri L, Ambresin A, Schorderet DF et al. Phenotype of three consanguineous Tunisian families with early-onset retinal degeneration caused by an R91W homozygous mutation in the RPE65 gene Graefes Arch Clin Exp Ophthalmol. 2006;244:1104-12.
  18. Heher KL, Traboulsi EI, Maumenee IH. The natural history of Leber's congenital amaurosis. Age-related findings in 35 patients. Ophthalmology 1992;99:241-5.
  19. Fulton AB, Hansen RM, Mayer DL. Vision in Leber congenital amaurosis. Arch Ophthalmol 1996;114:698-703.
  20. Perrault I, Rozet JM, Ghazi I et al. Different Functional Outcome of RetGC1 and RPE65 Gene Mutations in Leber Congenital Amaurosis. Am J Humn Genet 1999;64:1225-8.
  21. Lorenz B, Gyürüs P, Preising M et al. Early-onset severe rod-cone dystrophy in young children with RPE65 mutations. Invest Ophthalmol Vis Sci 2000;41:2735-42.
  22. Morimura H, Fishman GA, Grover SA, Fulton AB, Berson EL, Dryja TP. Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or Leber congenital amaurosis. Proc Natl Acad Sci USA 1998;95:3088-93.
  23. Walia S, Fishman GA, Jacobson SG et al. Visual Acuity in Patients with Leber's Congenital Amaurosis and Early Childhood-Onset Retinitis Pigmentosa. Ophthalmology 2010;117:1190-1198.